Prognosis and mortality of hypertrophic obstructive cardiomyopathy.
D000319:Adrenergic beta-Antagonists / Q000627:therapeutic use; D000328:Adult; D000367:Age Factors; D000787:Angina Pectoris / Q000150:complications; D000790:Angiocardiography; D001795:Blood Pressure Determination; D009202:Cardiomyopathies / Q000175:diagnosis / Q000188:drug therapy / Q000401:mortality; D002648:Child; D002675:Child, Preschool; D003645:Death, Sudden; D004417:Dyspnea / Q000150:complications; D004696:Endocarditis / Q000150:complications; D005260:Female; D005500:Follow-Up Studies; D006326:Heart Auscultation; D006801:Humans; D006973:Hypertension / Q000209:etiology; D008297:Male; D008875:Middle Aged; D011379:Prognosis; D011655:Pulmonary Embolism / Q000209:etiology; D013575:Syncope / Q000150:complications; D014717:Vertigo / Q000150:complications
D000319:Adrenergic beta-Antagonists